Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Serina Therapeutics (SER) Tax Provisions (2019)

Serina Therapeutics (SER) has disclosed Tax Provisions for 1 consecutive years, with $18000.0 as the latest value for Q4 2019.

  • Quarterly Tax Provisions changed N/A to $18000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $148000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $18000.0 for FY2025, N/A changed from the prior year.
  • Tax Provisions hit $18000.0 in Q4 2019 for Serina Therapeutics, down from $54000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $73000.0 in Q1 2019 to a low of $3000.0 in Q2 2019.